A detailed history of Continuum Advisory, LLC transactions in Sanofi stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,051 shares of SNY stock, worth $50,437. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,051
Previous 1,094 3.93%
Holding current value
$50,437
Previous $53,000 13.21%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$48.54 - $58.53 $2,087 - $2,516
-43 Reduced 3.93%
1,051 $60,000
Q2 2024

Jul 19, 2024

BUY
$45.39 - $50.36 $1,134 - $1,259
25 Added 2.34%
1,094 $53,000
Q1 2024

May 10, 2024

SELL
$45.75 - $52.48 $533,811 - $612,336
-11,668 Reduced 91.61%
1,069 $51,000
Q4 2023

Feb 14, 2024

SELL
$43.13 - $54.79 $114,208 - $145,083
-2,648 Reduced 17.21%
12,737 $633,000
Q3 2023

Nov 13, 2023

BUY
$50.95 - $55.2 $134,711 - $145,948
2,644 Added 20.75%
15,385 $825,000
Q2 2023

Dec 13, 2023

BUY
$50.45 - $57.18 $10,190 - $11,550
202 Added 1.61%
12,741 $686,000
Q2 2023

Aug 10, 2023

BUY
$50.45 - $57.18 $10,190 - $11,550
202 Added 1.61%
12,741 $686,000
Q1 2023

Dec 13, 2023

BUY
$45.86 - $54.45 $11,648 - $13,830
254 Added 2.07%
12,539 $682,000
Q1 2023

May 12, 2023

BUY
$45.86 - $54.45 $11,648 - $13,830
254 Added 2.07%
12,539 $682,000
Q4 2022

Dec 13, 2023

SELL
$38.86 - $48.55 $31,126 - $38,888
-801 Reduced 6.12%
12,285 $594,000
Q4 2022

Feb 10, 2023

SELL
$38.86 - $48.55 $31,126 - $38,888
-801 Reduced 6.12%
12,285 $594,000
Q3 2022

Dec 13, 2023

BUY
$37.22 - $100.5 $7,890 - $21,306
212 Added 1.65%
13,086 $497,000
Q3 2022

Nov 08, 2022

BUY
$37.22 - $100.5 $7,890 - $21,306
212 Added 1.65%
13,086 $498,000
Q2 2022

Dec 13, 2023

BUY
$48.99 - $57.46 $334,454 - $392,279
6,827 Added 112.9%
12,874 $644,000
Q2 2022

Aug 15, 2022

BUY
$48.99 - $57.46 $334,454 - $392,279
6,827 Added 112.9%
12,874 $644,000
Q1 2022

Dec 13, 2023

SELL
$48.48 - $53.65 $452,706 - $500,983
-9,338 Reduced 60.7%
6,047 $310,000
Q1 2022

May 17, 2022

BUY
$48.48 - $53.65 $293,158 - $324,421
6,047 New
6,047 $316,000
Q1 2019

May 18, 2021

SELL
$40.83 - $45.43 $365,836 - $407,052
-8,960 Closed
0 $0
Q4 2018

May 18, 2021

SELL
$41.48 - $45.59 $27,998 - $30,773
-675 Reduced 7.01%
8,960 $389,000
Q3 2018

May 18, 2021

BUY
$40.0 - $44.84 $32,240 - $36,141
806 Added 9.13%
9,635 $434,000
Q2 2018

May 18, 2021

BUY
$37.63 - $41.22 $25,437 - $27,864
676 Added 8.29%
8,829 $353,000
Q1 2018

May 18, 2021

BUY
$38.98 - $45.76 $53,948 - $63,331
1,384 Added 20.45%
8,153 $327,000
Q4 2017

May 18, 2021

SELL
$42.86 - $50.61 $42 - $50
-1 Reduced 0.01%
6,769 $291,000
Q3 2017

May 18, 2021

SELL
$47.04 - $50.34 $7,432 - $7,953
-158 Reduced 2.28%
6,770 $337,000
Q2 2017

May 18, 2021

BUY
N/A
1,138 Added 19.65%
6,928 $332,000
Q1 2017

May 18, 2021

BUY
N/A
5,790
5,790 $262,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.